The role of mitochondria in mood disorders: from physiology to pathophysiology and to treatment

Giménez-Palomo, Anna, Dodd, Seetal, Anmella, Gerard, Carvalho, Andre F., Scaini, Giselli, Quevedo, Joao, Pacchiarotti, Isabella, Vieta, Eduard +1 more·2021·Frontiers in Psychiatry

Cites (381)

Items 201–379 of 379

  1. Protracted lithium treatment protects against the ER stress elicited by thapsigargin in rat PC12 cells: roles of intracellular calcium, GRP78 and Bcl-2
    T Hiroi, Huafeng Wei, Christopher J. Hough, Peter R. Leeds, D M Chuang · 2005 · The Pharmacogenomics Journal
  2. Inositol as an add‐on treatment for bipolar depression
    KN Roy Chengappa, Joseph Levine, Samuel Gershon, Alan G. Mallinger, Antonio Y. Hardan, Anthony H. Vagnucci, Bruce G. Pollock, James F. Luther, Joan Buttenfield, Steve Verfaille et al. · 2000 · Bipolar Disorders
  3. Antidepressant Drugs Diversely Affect Autophagy Pathways in Astrocytes and Neurons—Dissociation from Cholesterol Homeostasis
    Jürgen Zschocke, Nicole Zimmermann, Barbara Berning, Vanessa Ganal, Florian Holsboer, Theo Rein · 2011 · Neuropsychopharmacology
  4. DISC1-dependent Regulation of Mitochondrial Dynamics Controls the Morphogenesis of Complex Neuronal Dendrites
    Rosalind Norkett, Souvik Modi, Nicol Birsa, Talia A. Atkin, Davor Ivankovic, Manav Pathania, Svenja Verena Trossbach, Carsten Korth, Warren D. Hirst, Josef T. Kittler · 2015 · Journal of Biological Chemistry
  5. N-acetyl cysteine add-on treatment for bipolar II disorder: a subgroup analysis of a randomized placebo-controlled trial
    Pedro Vieira da Silva Magalhães, Olivia May Dean, Ashley Ian Bush, David Copolov, Gin Singh Malhi, Kristy Kohlmann, Sue Jeavons, Ian Schapkaitz, Murray Anderson‐Hunt, M. Berk · 2010 · Journal of Affective Disorders
  6. Gene expression differences in bipolar disorder revealed by cDNA array analysis of post‐mortem frontal cortex
    Yarema B. Bezchlibnyk, Junfeng Wang, Glenda M. McQueen, Lionel Trevor Young · 2001 · Journal of Neurochemistry
  7. The role of mitochondrial dysfunction in psychiatric disease
    Fernando Scaglia · 2010 · Developmental Disabilities Research Reviews
  8. Bupropion and venlafaxine responders differ in pretreatment regional cerebral metabolism in unipolar depression
    John T. Little, Terence A. Ketter, Tim A. Kimbrell, Robert T. Dunn, Brenda E. Benson, Mark W Willis, David A. Luckenbaugh, Robert M. Post · 2005 · Biological Psychiatry
  9. Maintenance N-acetyl cysteine treatment for bipolar disorder: A double-blind randomized placebo controlled trial
    Michael Berk, Olivia May Dean, Sue Cotton, Clarissa Severino Gama, Flávio Pereira Kapczinski, Brisa Simões Fernandes, Kristy Kohlmann, Susan Jeavons, Karen Hewitt, Kirsteen Moss et al. · 2012 · BMC Medicine
  10. Differential Display PCR Reveals Novel Targets for the Mood-Stabilizing Drug Valproate Including the Molecular Chaperone GRP78
    Junfeng Wang, Christopher D. Bown, L. Trevor Young · 1999 · Molecular Pharmacology
  11. The subjective and cognitive effects of acute phenylalanine and tyrosine depletion in patients recovered from depression
    Roiser, Jonathan P, McLean, Andrew, Ogilvie, Alan D, Blackwell, Andrew D, Bamber, Diane J, Goodyer, Ian, Jones, Peter B, Sahakian, Barbara J · 2005 · Neuropsychopharmacology
  12. Abnormalities in High-Energy Phosphate Metabolism in First-Episode Bipolar Disorder Measured Using 31P-Magnetic Resonance Spectroscopy
    Fei Du, Çağrı Yüksel, Virginie‐Anne Chouinard, Polly Huynh, Kyle P. Ryan, Bruce M. Cohen, Döst Öngür · 2017 · Biological Psychiatry
  13. Effect of fluoxetine on rat liver mitochondria
    Souza, Maria Eliza J., Polizello, Ana Cristina M., Uyemura, Sérgio Akira, Castro-Silva, Orlando, Curti, Carlos · 1994 · Biochemical Pharmacology
  14. Role of mitochondrial DNA in calcium signaling abnormality in bipolar disorder
    Tadafumi Kato · 2008 · Cell Calcium
  15. Modulation of Protein Kinase C Isozymes and Substrates by Lithium: The Role of Myo-inositol
    Husseini K. Manji · 1996 · Neuropsychopharmacology
  16. TSPO upregulation in bipolar disorder and concomitant downregulation of mitophagic proteins and NLRP3 inflammasome activation
    Giselli Scaini, Tatiana Barichello, Gabriel R. Fries, Elizabeth A. Kennon, Taylor Andrews, Bobby Nix, Giovana B. Zunta‐Soares, Samira Silva Valvassori, Jair C. Soares, João Quevedo · 2018 · Neuropsychopharmacology
  17. Mitochondrial Mutations and Polymorphisms in Psychiatric Disorders
    Adolfo Sequeira, Maureen V. Martin, Brandi L. Rollins, Emily A. Moon, William E. Bunney, Fabio M. Macciardi, Sara Lupoli, Erin N. Smith, John R. Kelsoe, Christophe N. Magnan et al. · 2012 · Frontiers in Genetics
  18. Olanzapine and quetiapine protect PC12 cells from β-amyloid peptide25-35-induced oxidative stress and the ensuing apoptosis
    Haitao Wang, Haiyun Xu, Lillian E. Dyck, Xinmin Li · 2005 · Journal of Neuroscience Research
  19. Cofactor treatment improves ATP synthetic capacity in patients with oxidative phosphorylation disorders
    Barbara J. Marriage, Michael Thomas Clandinin, Ian M. MacDonald, D. Moira Glerum · 2004 · Molecular Genetics and Metabolism
  20. Decrease in creatine kinase messenger RNA expression in the hippocampus and dorsolateral prefrontal cortex in bipolar disorder
    Matthew L. MacDonald, Alipi V. Naydenov, Melissa S. Chu, David Matzilevich, Christine L. Konradi · 2006 · Bipolar Disorders
  21. Valproic acid induces extracellular signal-regulated kinase 1/2 activation and inhibits apoptosis in endothelial cells
    Martin Michaelis, Tatyana O. Suhan, U R Michaelis, K. Van Beek, Florian Rothweiler, Lars Tausch, Oliver Werz, Daniel Eikel, Martin Zörnig, Heinz Nau et al. · 2005 · Cell Death and Differentiation
  22. Effects of Exogenous Melatonin Administration and Withdrawal in Five Patients With Rapid-Cycling Bipolar Disorder
    Ellen Leibenluft, Susana Feldman‐Naim, Erick H. Turner, Thomas A. Wehr, Norman E. Rosenthal · 1997 · The Journal of Clinical Psychiatry
  23. Quality matters: how does mitochondrial network dynamics and quality control impact on mtDNA integrity?
    Busch, Karin B., Kowald, Axel, Spelbrink, Johannes N. · 2014 · Philosophical Transactions of the Royal Society B Biological Sciences
  24. Aging brain: effect of acetyl-l-carnitine treatment on rat brain energy and phospholipid metabolism. A study by31P and1H NMR spectroscopy
    Tommaso Aureli, Alfredo Miccheli, Rita Ricciolini, Maria Enrica Di Cocco, Maria Teresa Ramacci, Luciano Angelucci, Orlando Ghirardi, Filippo Conti · 1990 · Brain Research
  25. Melatonin add-on in manic patients with treatment resistant insomnia
    Giuseppe Bersani, Alessandra Garavini · 2000 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  26. Regulation of ER stress proteins by valproate: therapeutic implications
    Christopher D. Bown, Junfeng Wang, Biao Chen, Lionel Trevor Young · 2002 · Bipolar Disorders
  27. Differential Regulatory Mechanism of Ca 2+ /Calmodulin-Dependent Protein Kinase Kinase Isoforms
    Hiroshi Tokumitsu, Masato Iwabu, Yumi Ishikawa, Ryōji Kobayashi · 2001 · Biochemistry
  28. Mood stabilizing drug lithium increases expression of endoplasmic reticulum stress proteins in primary cultured rat cerebral cortical cells
    Li Shao, Xiujun Sun, Li Xu, Lionel Trevor Young, Junfeng Wang · 2005 · Life Sciences
  29. Major depressive disorder and nutritional medicine: a review of monotherapies and adjuvant treatments
    Jerome J. Sarris, Niikee C. Schoendorfer, David John Kavanagh · 2009 · Nutrition Reviews
  30. Perturbations in the apoptotic pathway and mitochondrial network dynamics in peripheral blood mononuclear cells from bipolar disorder patients
    Giselli Scaini, Gabriel R. Fries, Samira Silva Valvassori, Cristian Zeni, Giovana B. Zunta‐Soares, M Berk, Jair C. Soares, João Quevedo · 2017 · Translational Psychiatry
  31. A double-blind, randomised, controlled clinical trial of acetyl-l-carnitine vs. amisulpride in the treatment of dysthymia
    Raffaella Zanardi, Enrico Smeraldi · 2005 · European Neuropsychopharmacology
  32. A Placebo-Controlled Trial of Acetyl-L-Carnitine and α-Lipoic Acid in the Treatment of Bipolar Depression
    Brian P. Brennan, John Eric Jensen, James I. Hudson, Caitlin E. Coit, Ashley Beaulieu, Harrison Graham Pope, Perry Franklin Renshaw, Bruce M. Cohen · 2013 · Journal of Clinical Psychopharmacology
  33. Effects of a branched-chain amino acid drink in mania
    Antonina Scarnà, Harm J. Gijsman, Sarah F. B. McTavish, Catherine J. Harmer, Philip J. Cowen, Guy M. Goodwin · 2003 · The British Journal of Psychiatry
  34. 31P‐MRS study of acetyl‐ L ‐carnitine treatment in geriatric depression: preliminary results
    Jay W. Pettegrew, Joseph Levine, Samuel Gershon, Jeffrey A. Stanley, David Servan‐Schreiber, Kanagasabai Panchalingam, Richard J. McClure · 2002 · Bipolar Disorders
  35. Relations Between Tocopherol Depletion and Coenzyme Q During Lipid Peroxidation in rat Liver Mitochondria
    Heiko Noack, Ullrich Kube, Wolfgang Augustin · 1994 · Free Radical Research
  36. Open trial of S-adenosylmethionine for treatment of depression
    Joseph F. Lipinski, B M Cohen, Frances Rachel Frankenburg, Mauricio F. Tohen, CHRISTINE M. WATERNAUX, Richard I. Altesman, Barbara Pendleton Jones, Peter Q. Harris · 1984 · American Journal of Psychiatry
  37. The neurobiology of bipolar disorder: identifying targets for specific agents and synergies for combination treatment
    Ana C. Andreazza, Lionel Trevor Young · 2013 · The International Journal of Neuropsychopharmacology
  38. Pluripotent Stem Cell Metabolism and Mitochondria: Beyond ATP
    Jarmon G. Lees, David K. Gardner, Alexandra J. Harvey · 2017 · Stem Cells International
  39. Journal of Parkinson’s disease & Alzheimer’s disease
    William Kirby Gottschalk, Michael William Lutz, Yu Ting He, Ann M. Saunders, Daniel K. Burns, Allen D. Roses, Ornit Chiba‐Falek · 2014 · Journal of Parkinson’s Disease and Alzheimer’s Disease
  40. Adjunctive nutraceuticals with standard pharmacotherapies in bipolar disorder: a systematic review of clinical trials
    Jerome J. Sarris, David Mischoulon, Isaac Schweitzer · 2011 · Bipolar Disorders
  41. Inositol augmentation of lithium or valproate for bipolar depression
    A E, Evins, Demopulos, Christina, Yovel, Iftah, Culhane, Melissa, Ogutha, Jacqueline, Grandin, Louisa D, Nierenberg, Andrew A, Sachs, Gary S · 2006 · Bipolar Disorders
  42. Glutathione S‐transferase is a novel target for mood stabilizing drugs in primary cultured neurons
    Junfeng Wang, Li Shao, Xiujun Sun, Lionel Trevor Young · 2004 · Journal of Neurochemistry
  43. Mitochondrial modulators for bipolar disorder: A pathophysiologically informed paradigm for new drug development
    Andrew Alan Nierenberg, Christine Kansky, Brian P. Brennan, Richard Charles Shelton, Roy H. Perlis, Dan Vlad Iosifescu · 2012 · Australian & New Zealand Journal of Psychiatry
  44. Exocytosis and Endocytosis of Synaptic Vesicles and Functional Roles of Vesicle Pools: Lessons from the Drosophila Neuromuscular Junction
    Hiroshi Kuromi, Yoshiaki Kidokoro · 2005 · The Neuroscientist
  45. Effects of antiepileptic drugs on mitochondrial functions, morphology, kinetics, biogenesis, and survival
    Josef Finsterer, Fulvio Alexandre Scorza · 2017 · Epilepsy Research
  46. Fluoxetine interacts with the lipid bilayer of the inner membrane in isolated rat brain mitochondria, inhibiting electron transport and F1F0-ATPase activity
    Curti, Carlos, Mingattao, Fábio E., Polizello, Ana C.M., Galastri, Leandro O., Uyemura, Sérgio A., Santos, Antonio C. · 1999 · Molecular and Cellular Biochemistry
  47. Inflammation as the Common Biological Link Between Depression and Cardiovascular Diseases: Can Carnosine Exert a Protective Role?
    Giuseppe Caruso, Claudia Giuseppina Fresta, Margherita Grasso, Rosa Santangelo, Giuseppe Lazzarino, Susan M. Lunte, Filippo Caraci · 2019 · Current Medicinal Chemistry
  48. Trehalose induced antidepressant-like effects and autophagy enhancement in mice
    N. Kara, Lilah Toker, Galila Agam, Grant W. Anderson, R.H. Belmaker, Haim Einat · 2013 · Psychopharmacology
  49. Efficacy of S-adenosyl-L-methionine in speeding the onset of action of imipramine
    Carlos Berlanga, Héctor A. Ortega-Soto, Martha Ontiveros, Héctor Sentíes · 1992 · Psychiatry Research
  50. Placebo-Controlled Adjunctive Trial of Pramipexole in Patients With Bipolar Disorder
    Katherine E. Burdick, Raphael J. Braga, Charles U Nnadi, Yaniv Shaya, Walter H. Stearns, Anil K. Malhotra · 2011 · The Journal of Clinical Psychiatry
  51. Mitochondrial DNA variation and increased oxidative damage in euthymic patients with bipolar disorder
    Cheng‐Chen Chang, Shaw‐Hwa Jou, Ta‐Tsung Lin, Chin‐San Liu · 2014 · Psychiatry and Clinical Neurosciences
  52. Quantitative analysis of mitochondrial DNA deletions in the brains of patients with bipolar disorder and schizophrenia
    Chihiro Kakiuchi, Mizuho Ishiwata, Mizue Kametani, Cheryl Nelson, Kazuya Iwamoto, Tadafumi Kato · 2005 · The International Journal of Neuropsychopharmacology
  53. Carbamazepine inhibition of N-methyl-D-aspartate-evoked calcium influx in rat cerebellar granule cells.
    Christopher J. Hough, Robert P. Irwin, Xi Gao, Michael A. Rogawski, D M Chuang · 1996 · Journal of Pharmacology and Experimental Therapeutics
  54. Mitochondria in health and disease
    Sanjiban Chakrabarty, Shama Prasada Kabekkodu, Rana Pratap Singh, Kumarasamy Thangaraj K, Keshav Kumar Singh, Kapaettu Satyamoorthy · 2018 · Mitochondrion
  55. Lithium and valproate modulate energy metabolism in an animal model of mania induced by methamphetamine
    Gustavo Feier, Samira Silva Valvassori, Roger B. Varela, Wilson R. Resende, Daniela Vicente Bavaresco, Meline Oliveira dos Santos Morais, Giselli Scaini, Mônica L. Andersen, Emilio Luiz STRECK, João Quevedo · 2012 · Pharmacology Biochemistry and Behavior
  56. Modulation of phosphoinositide–protein kinase C signal transduction by omega-3 fatty acids: Implications for the pathophysiology and treatment of recurrent neuropsychiatric illness
    Robert K. McNamara, Michelle M. Ostrander, William A. Abplanalp, Neil M. Richtand, Stephen C. Benoit, Debbie J. Clegg · 2006 · Prostaglandins Leukotrienes and Essential Fatty Acids
  57. Effect of controlled-release melatonin on sleep quality, mood, and quality of life in subjects with seasonal or weather-associated changes in mood and behaviour
    Sami Leppämäki, Timo Partonen, Olli Vakkuri, Jouko K Lönnqvist, Markku Partinen, Moshe Laudon · 2003 · European Neuropsychopharmacology
  58. DISC1 Modulates Neuronal Stress Responses by Gate-Keeping ER-Mitochondria Ca2+ Transfer through the MAM
    Sung Jin Park, Su Been Lee, Yeongjun Suh, Su-Jeong Kim, Namgyu Lee, Ji‐Ho Hong, Cana Park, Youngsik Woo, Koko Ishizuka, Joung‐Hun Kim et al. · 2017 · Cell Reports
  59. Influence of mitochondrial enzyme deficiency on adult neurogenesis in mouse models of neurodegenerative diseases
    Noel Ylagan Calingasan, Daniel J. Ho, Elizabeth J. Wille, M.V. Campagna, J. Ruan, Magali Dumont, Le Yang, Qingli Shi, Gary E. Gibson, M. Flint Beal · 2008 · Neuroscience
  60. Lithium Desensitizes Brain Mitochondria to Calcium, Antagonizes Permeability Transition, and Diminishes Cytochrome c Release
    Natalia Shalbuyeva, Tatiana Brustovetsky, Nickolay Brustovetsky · 2007 · Journal of Biological Chemistry
  61. Chronic valproate treatment increases expression of endoplasmic reticulum stress proteins in the rat cerebral cortex and hippocampus
    Biao Chen, Jun Feng Wang, Lionel Trevor Young · 2000 · Biological Psychiatry
  62. Rapid Acting Antidepressants in Chronic Stress Models: Molecular and Cellular Mechanisms
    Hare, Brendan D., Ghosal, Sriparna, Duman, Ronald S. · 2017 · Chronic Stress
  63. Second generation antipsychotic-induced mitochondrial alterations: Implications for increased risk of metabolic syndrome in patients with schizophrenia
    Giselli Scaini, João Quevedo, Dawn I. Velligan, David Leland Roberts, Henriette Raventós, Consuelo Walss‐Bass · 2018 · European Neuropsychopharmacology
  64. The Complex Interaction of Mitochondrial Genetics and Mitochondrial Pathways in Psychiatric Disease
    Ari B. Cuperfain, Zhi Lun Zhang, James L. Kennedy, Vanessa Faria Gonçalves · 2018 · Complex Psychiatry
  65. Transmitochondrial embryonic stem cells containing pathogenic mtDNA mutations are compromised in neuronal differentiation
    Denise M. Kirby, Katherine J. Rennie, Tora Kirthika Smulders-Srinivasan, Rebeca Acín‐Pérez, Miles A. Whittington, José Antonio Enrı́quez, Andrew J. Trevelyan, Douglass M. Turnbull, Robert Neil Lightowlers · 2009 · Cell Proliferation
  66. Genes Linking Mitochondrial Function, Cognitive Impairment and Depression are Associated with Endophenotypes Serving Precision Medicine
    Péter Petschner, Xénia Gonda, Dániel Baksa, Nóra Eszlári, Michael Trivaks, Gabriella Juhász, György Bagdy · 2017 · Neuroscience
  67. Antidepressant effect of Shudihuang on mice exposed to unpredictable chronic mild stress
    Di Zhang, Xue-Sen Wen, Xueyan Wang, Min Shi, Yu Xia Zhao · 2009 · Journal of Ethnopharmacology
  68. Altered IMPA2 gene expression and calcium homeostasis in bipolar disorder
    I-S Yoon, P P Li, K. W. Michael Siu, James L. Kennedy, R.G. Cooke, Sagar V. Parikh, Jerry J. Warsh · 2001 · Molecular Psychiatry
  69. Aberrant Intracellular Calcium Signaling in Olfactory Neurons From Patients With Bipolar Disorder
    Chang-Gyu Hahn, George Gomez, Diego Restrepo, Eitan A. Friedman, Richard C. Josiassen, Edmund A. Pribitkin, Louis Dale Lowry, Robert Gallop, Nancy E. Rawson · 2005 · American Journal of Psychiatry
  70. Lactate in bipolar disorder: A systematic review and meta‐analysis
    Heidi Kuang, Angela Duong, Hyunjin Jeong, Kassandra A. Zachos, Ana C. Andreazza · 2018 · Psychiatry and Clinical Neurosciences
  71. The Many Faces of Mitochondrial Dysfunction in Depression: From Pathology to Treatment
    Caruso, Giuseppe, Benatti, Cristina, Blom, Joan M.C., Caraci, Filippo, Tascedda, Fabio · 2019 · Frontiers in Pharmacology
  72. Effects of Metabolic Modifiers Such as Carnitines, Coenzyme Q10, and PUFAs against Different Forms of Neurotoxic Insults: Metabolic Inhibitors, MPTP, and Methamphetamine
    Ashraf Virmani, Franco Gaetani, ZBIGNIEW K. BINIENDA · 2005 · Annals of the New York Academy of Sciences
  73. Ketosis and bipolar disorder: controlled analytic study of online reports
    Iain H. Campbell, Harry J. Campbell · 2019 · BJPsych Open
  74. Chronic Lithium Treatment has Antioxidant Properties but does not Prevent Oxidative Damage Induced by Chronic Variate Stress
    Ana Paula Santana de Vasconcellos, Fabiane Nieto, Leonardo Machado Crema, Luísa Amália Diehl, Lúcia Maria de Almeida, Martha Elisa Prediger, Elizabete Rocha da Rocha, Carla Dalmaz · 2006 · Neurochemical Research
  75. Activities of mitochondrial respiratory chain complexes in platelets of patients with Alzheimer's disease and depressive disorder
    Zdeněk Fišar, Hana Hansíková, Jana Křížová, Roman Jirák, Eva Kitzlerová, Martina Zvěřová, Jana Hroudová, László Wenchich, J Zeman, Jiří Raboch · 2019 · Mitochondrion
  76. Connectivity between mitochondrial functions and psychiatric disorders
    Jana Hroudová, Zdeněk Fišar · 2011 · Psychiatry and Clinical Neurosciences
  77. Lower high-density lipoprotein cholesterol and increased omega-6 polyunsaturated fatty acids in first-degree relatives of bipolar patients
    Sjacko Sobczak, Adriaan Honig, A. Christophe, Michael H. J. Maes, R. van Helsdingen, An S. De Vriese, Wim J. Riedel · 2004 · Psychological Medicine
  78. Fluoxetine affects hippocampal plasticity, apoptosis and depressive-like behavior of chronically isolated rats
    Ana D. Djordjevic, Jelena Djordjevic, Ivana Elaković, Miroslav Adžić, Gordana M. Matić, Marija B. Radojcic · 2011 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  79. Transcriptional Evidence for the Role of Chronic Venlafaxine Treatment in Neurotrophic Signaling and Neuroplasticity Including also Glutatmatergic- and Insulin-Mediated Neuronal Processes
    Viola Tamási, Péter Petschner, Csaba Ádori, Eszter Kirilly, Rómeó D. Andó, László Tóthfalusi, Gabriella Juhász, György Bagdy · 2014 · PLoS ONE
  80. Antidepressant Action on Mitochondrial Dysfunction in Psychiatric Disorders
    Adzic, Miroslav, Brkic, Zeljka, Bulajic, Sonja, Mitic, Milos, Radojcic, Marija B. · 2016 · Drug Development Research
  81. Mitochondrial energy metabolism of rat hippocampus after treatment with the antidepressants desipramine and fluoxetine
    Roberto Federico Villa, Federica Ferrari, Laura Bagini, Antonella Gorini, Nicoletta Brunello, Fabio Tascedda · 2017 · Neuropharmacology
  82. Mitochondria in the life and death of neurons
    Samantha L. Budd, David G. Nicholls · 1998 · Essays in Biochemistry
  83. Effects of <scp>N</scp>‐acetyl cysteine on cognitive function in bipolar disorder
    Dean, Olivia M., Bush, Ashley I., Copolov, David L., Kohlmann, Kristy, Jeavons, Susan, Schapkaitz, Ian, Anderson‐Hunt, Murray, Berk, Michael · 2012 · Psychiatry and Clinical Neurosciences
  84. Pretreatment regional brain glucose uptake in the midbrain on PET may predict remission from a major depressive episode after three months of treatment
    Matthew S. Milak, Ramin V. Parsey, Leilani Lee, María A. Oquendo, Doreen M. Olvet, Francoise Eipper, Kevin M Malone, Joseph John Mann · 2009 · Psychiatry Research Neuroimaging
  85. Diet and Bipolar Disorder: A Review of Its Relationship and Potential Therapeutic Mechanisms of Action
    Adrian L. Lopresti, Felice N. Jacka · 2015 · The Journal of Alternative and Complementary Medicine
  86. Coenzyme Q10 Effects on Creatine Kinase Activity and Mood in Geriatric Bipolar Depression
    Brent P. Forester, Chun S. Zuo, Caitlin T. Ravichandran, David G. Harper, Fei Du, Hanna Kim, Bruce M. Cohen, Perry Franklin Renshaw · 2012 · Journal of Geriatric Psychiatry and Neurology
  87. A preliminary investigation on the efficacy of <i>N</i> -acetyl cysteine for mania or hypomania
    Vieira da Silva Magalhães, Pedro, Dean, Olivia M, Bush, Ashley I, Copolov, David L, Malhi, Gin S, Kohlmann, Kristy, Jeavons, Susan, Schapkaitz, Ian, Anderson-Hunt, Murray, Berk, Michael · 2013 · Australian &amp; New Zealand Journal of Psychiatry
  88. Increased oxidative stress in the mitochondria isolated from lymphocytes of bipolar disorder patients during depressive episodes
    Samira Silva Valvassori, Daniela Vicente Bavaresco, Gustavo Feier, Kelen C. C. Recco, Amanda Valnier Steckert, Roger B. Varela, Cenita Pereira Borges, Milena Carvalho‐Silva, Lara Mezari Gomes, Emilio Luiz STRECK et al. · 2018 · Psychiatry Research
  89. Folic acid efficacy as an alternative drug added to sodium valproate in the treatment of acute phase of mania in bipolar disorder: a double‐blind randomized controlled trial
    Ashkan Heshmatzadeh Behzadi, Z. Omrani, Majid Chalian, Sara Asadi, M. Ghadiri · 2009 · Acta Psychiatrica Scandinavica
  90. Differential effects of olanzapine on the gene expression of superoxide dismutase and the low affinity nerve growth factor receptor
    Xinmin Li, Jennifer Chlan‐Fourney, Augusto V. Juorio, Vern L. Bennett, Satish Shrikhande, David L. Keegan, Qi Jin, Alan A. Boulton · 1999 · Journal of Neuroscience Research
  91. The Switch Mechanism and the Bipolar/Unipolar Dichotomy
    M. W. P. Carney, T. K. N. Chary, Teodoro Bottiglieri, Edward Henry Reynolds · 1989 · The British Journal of Psychiatry
  92. CARNITINE ESTERS PREVENT OXIDATIVE STRESS DAMAGE AND ENERGY DEPLETION FOLLOWING TRANSIENT FOREBRAIN ISCHAEMIA IN THE RAT HIPPOCAMPUS
    Abdulhakeem A. Al‐Majed, Mohamed M. Sayed‐Ahmed, Faisal Haitham Alomar, Abdulaziz A. Al‐Yahya, Abdulaziz M. Aleisa, Othman A. Al‐Shabanah · 2006 · Clinical and Experimental Pharmacology and Physiology
  93. Contribution of neural cell death to depressive phenotypes of streptozotocin-induced diabetic mice
    Cheng Chen, Yun Wang, Juan Zhang, Lian Ma, Jiang Gu, Guyu Ho · 2014 · Disease Models & Mechanisms
  94. Valproic acid metabolites inhibit dihydrolipoyl dehydrogenase activity leading to impaired 2-oxoglutarate-driven oxidative phosphorylation
    Paula B. Luis, Jos P.N. Ruiter, Cátia C.P. Aires, Graça Soveral, Isabel Tavares de Almeida, Marinus Durán, Ronald J. A. Wanders, Margarida F. B. Silva · 2007 · Biochimica et Biophysica Acta (BBA) - Bioenergetics
  95. Lithium ameliorates lipopolysaccharide-induced neurotoxicity in the cortex and hippocampus of the adult rat brain
    Muhammad Sohail Khan, Tahir Ali, Noman Bin Abid, Myeung Hoon Jo, Amjad Khan, Min Woo Kim, Gwang Ho Yoon, Eun Woo Cheon, Shafiq Ur Rehman, Myeong Ok Kim · 2017 · Neurochemistry International
  96. Targeting mitochondrially mediated plasticity to develop improved therapeutics for bipolar disorder
    Rafael T de Sousa, Rodrigo Machado‐Vieira, Carlos A. Zarate, Husseini K. Manji · 2014 · Expert Opinion on Therapeutic Targets
  97. Effect of dietary fat and the circadian clock on the expression of brain-derived neurotrophic factor (BDNF)
    Yoni Genzer, Maayan Dadon‐Freiberg, Chen Burg, Nava Chapnik, Oren Froy · 2016 · Molecular and Cellular Endocrinology
  98. Bcl-2 SNP rs956572 associates with disrupted intracellular calcium homeostasis in bipolar I disorder
    Takuji Uemura, Marty Green, Timothy W. Corson, Tatiana Perova, Peter P. Li, Jerry J. Warsh · 2011 · Bipolar Disorders
  99. Activity of mitochondrial respiratory chain is increased by chronic administration of antidepressants
    Giselli Scaini, Débora D. Maggi, Bruna Tramontin De-Nês, Cinara Ludvig Gonçalves, Gabriela Kozuchovski Ferreira, Brena P. Teodorak, Gisele Daiane Bez, Gustavo C. Ferreira, Patrícia Fernanda Schuck, João Quevedo et al. · 2011 · Acta Neuropsychiatrica
  100. Glutathione mediated reductive activation and mitochondrial dysfunction play key roles in lithium induced oxidative stress and cytotoxicity in liver
    Mohammad Reza Eskandari, Javad Khalili Fard, Mir‐Jamal Hosseini, Jalal Pourahmad · 2012 · BioMetals
  101. Defects of Mitochondrial Electron Transport Chain in Bipolar Disorder: Implications for Mood-Stabilizing Treatment
    Junfeng Wang · 2007 · The Canadian Journal of Psychiatry
  102. Putative neuroprotective pharmacotherapies to target the staged progression of mental illness
    Oliver D’Arcy Robertson, Nieves G. Coronado, Rickinder Sethi, Michael Berk, Seetal Dodd · 2019 · Early Intervention in Psychiatry
  103. Reversible Transdominant Inhibition of a Metabolic Pathway
    Christian Vélot, Paul A. Srere · 2000 · Journal of Biological Chemistry
  104. A controlled clinical trial of l-tryptophan in acute mania
    Guy Chouinard, Simon N. Young, Lawrence Annable · 1985 · Biological Psychiatry
  105. Dynamic Changes of the Mitochondria in Psychiatric Illnesses: New Mechanistic Insights From Human Neuronal Models
    Rupali Srivastava, Travis E. Faust, Adriana Ramos, Koko Ishizuka, Akira Sawa · 2018 · Biological Psychiatry
  106. Effects of alpha‐lipoic acid in an animal model of mania induced by d ‐amphetamine
    Danielle S. Macêdo, Camila D Medeiros, R.C. Cordeiro, Francisca Cléa Florenço de Sousa, Junia Vieira Dos Santos, Thomás A Morais, Thomas N. Hyphantis, Roger S. McIntyre, João Quevedo, Andre Ferrer Carvalho · 2012 · Bipolar Disorders
  107. Energetic and Dynamic: How Mitochondria Meet Neuronal Energy Demands
    Dzhamilja Safiulina, Allen Kaasik · 2013 · PLoS Biology
  108. Quantification of total mitochondrial DNA and mitochondrial common deletion in the frontal cortex of patients with schizophrenia and bipolar disorder
    Sarven Sabunciyan, Elmar Kirches, Guido Krause, Bernhard Bogerts, Christian Mawrin, Ida Cirila Llenos, Serge Weis · 2006 · Journal of Neural Transmission
  109. Effect of desipramine and fluoxetine on energy metabolism of cerebral mitochondria
    Roberto Federico Villa, Federica Ferrari, Antonella Gorini, Nicoletta Brunello, Fabio Tascedda · 2016 · Neuroscience
  110. Mechanisms of action and clinical efficacy of NMDA receptor modulators in mood disorders
    Mehdi Ghasemi, Cristy Phillips, Atoossa Fahimi, Margaret Windy McNerney, Ahmad Salehi · 2017 · Neuroscience & Biobehavioral Reviews
  111. Investigation of mitochondrial DNA copy number in patients with major depressive disorder
    Jae Kyung Chung, Soo Young Lee, Mira Park, Eun-Jeong Joo, Soon Ae Kim · 2019 · Psychiatry Research
  112. L-acetylcarnitine in depressed elderly subjects. A cross-over study vs placebo.
    Enrico Tempesta, Lia Casella, C Pirrongelli, Luigi Janiri, Menotti Calvani, L Ancona · 1987 · PubMed
  113. Effects of lithium and valproate on hippocampus citrate synthase activity in an animal model of mania
    Cristiane Corrêa, Graziela Amboni, Lara Clemes Assis, Márcio R. Martins, Flávio Pereira Kapczinski, Emilio Luiz STRECK, João Quevedo · 2007 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  114. Brain region- and sex-specific modulation of mitochondrial glucocorticoid receptor phosphorylation in fluoxetine treated stressed rats: Effects on energy metabolism
    Miroslav Adžić, Iva Lukić, Miloš Mitić, Jelena Djordjevic, Ivana Elaković, Ana D. Djordjevic, Marija Krstic–Demonacos, Gordana M. Matić, Marija B. Radojcic · 2013 · Psychoneuroendocrinology
  115. Valproate inhibits the mitochondrial pyruvate‐driven oxidative phosphorylation in vitro
    Margarida F. B. Silva, Jos P.N. Ruiter, Lodewijk IJlst, Cornelis Jakobs, Marinus Durán, Isabel Tavares de Almeida, Ronald J. A. Wanders · 1997 · Journal of Inherited Metabolic Disease
  116. Lamotrigine inhibition of rotenone- or 1-methyl-4-phenylpyridinium-induced mitochondrial damage and cell death
    Yun Jeong Kim, Hyun Hee Ko, Eun Sook Han, Chung Soo Lee · 2007 · Brain Research Bulletin
  117. Histone deacetylase inhibitors reverse manic-like behaviors and protect the rat brain from energetic metabolic alterations induced by ouabain
    Jéssica Lopes-Borges, Samira Silva Valvassori, Roger B. Varela, Paula T. Tonin, Júlia S. Vieira, Cinara Ludvig Gonçalves, Emilio Luiz STRECK, João Quevedo · 2014 · Pharmacology Biochemistry and Behavior
  118. Gender-specific effects of fluoxetine on hippocampal glucocorticoid receptor phosphorylation and behavior in chronically stressed rats
    Miloš Mitić, Iva Simic, Jelena Djordjevic, Marija B. Radojcic, Miroslav Adžić · 2013 · Neuropharmacology
  119. Effects of Metabolic Modifiers Such as Carnitines, Coenzyme Q10, and PUFAs against Different Forms of Neurotoxic Insults: Metabolic Inhibitors, MPTP, and Methamphetamine
    Ashraf Virmani · 2005 · Annals of the New York Academy of Sciences
  120. Treatment with olanzapine, fluoxetine and olanzapine/fluoxetine alters citrate synthase activity in rat brain
    Fabiano Rosa Agostinho, Gislaine Z. Réus, Roberto B. Stringari, Karine F. Ribeiro, Ana K. Ferraro, Joana Benedet, Natália Rochi, Giselli Scaini, Emilio Luiz STRECK, João Quevedo · 2010 · Neuroscience Letters
  121. New Developments in the Genetics of Bipolar Disorder
    Gen Shinozaki, James B. Potash · 2014 · Current Psychiatry Reports
  122. Effects of mood stabilizers on oxidative stress-induced cell death signaling pathways in the brains of rats subjected to the ouabain-induced animal model of mania
    Samira Silva Valvassori, Wilson R. Resende, Jéssica Lopes-Borges, Edemilson Mariot, Gustavo Colombo Dal-Pont, Marcelo Fontana Vitto, Gabrielle da Luz, Cláudio Teodoro de Souza, João Quevedo · 2015 · Journal of Psychiatric Research
  123. Impaired glucose metabolism moderates the course of illness in bipolar disorder
    Rodrigo Barbachan Mansur, Lucas Bortolotto Rizzo, Camila M. Santos, Elson de Miranda Asevedo, Graccielle Rodrigues da Cunha, Mariane Nunes Noto, Mariana Pedrini, Maiara Zeni‐Graiff, Quirino Cordeiro, Roger S. McIntyre et al. · 2016 · Journal of Affective Disorders
  124. Mitochondrial DNA copy number of peripheral blood in bipolar disorder: The present study and a meta-analysis
    Naruhisa Yamaki, Ikuo Otsuka, Shusuke Numata, Masaya Yanagi, Kentaro Mouri, Satoshi Okazaki, Shuken Boku, Tadasu Horai, Tetsuro Ohmori, Osamu Shirakawa et al. · 2018 · Psychiatry Research
  125. Monitoring carnosine uptake by RAW 264.7 macrophage cells using microchip electrophoresis with fluorescence detection
    Claudia Giuseppina Fresta, Michael L. Hogard, Giuseppe Caruso, Elton E. Melo Costa, Giuseppe Lazzarino, Susan M. Lunte · 2016 · Analytical Methods
  126. Mitochondria: A Connecting Link in the Major Depressive Disorder Jigsaw
    Shilpa Sharma, Ravi Shankar Akundi · 2018 · Current Neuropharmacology
  127. CACNA1C rs1006737 genotype and bipolar disorder: Focus on intermediate phenotypes and cardiovascular comorbidity
    Xiao Ou, David Crane, Bradley J. MacIntosh, Lionel Trevor Young, Paul Daniel Arnold, Stephanie Hope Ameis, Benjamin I. Goldstein · 2015 · Neuroscience & Biobehavioral Reviews
  128. Effect of Antioxidant Diets on Mitochondrial Gene Expression in Rat Brain During Aging
    Vincenzo Giuseppe Nicoletti, Vittorio Marino, Christian Cuppari, Davide Licciardello, Davide Patti, V. Spina Purrello, A. M. Giuffrida Stella · 2005 · Neurochemical Research
  129. Quantitative analysis of the 4977-bp common deletion of mitochondrial DNA in postmortem frontal cortex from patients with bipolar disorder and schizophrenia
    Satoshi Fuke, Mizue Kametani, Tadafumi Kato · 2008 · Neuroscience Letters
  130. Gender differences in 12-week antidepressant treatment outcomes for a naturalistic secondary care cohort: The CRESCEND study
    Su-Jin Yang, Sun‐Young Kim, Robert J. Stewart, Jae‐Min Kim, Il‐Seon Shin, Sung-Won Jung, Min‐Soo Lee, Seung-Hee Jeong, Tae‐Youn Jun · 2011 · Psychiatry Research
  131. Disturbances of mitochondrial parameters to distinguish patients with depressive episode of bipolar disorder and major depressive disorder
    Martina Zvěřová, Jana Hroudová, Zdeněk Fišar, Hana Hansíková, Lucie Kališová, Eva Kitzlerová, Alena Lambertová, Jiří Raboch · 2019 · Neuropsychiatric Disease and Treatment
  132. Mitochondrial DNA copy number, damage, repair and degradation in depressive disorder
    Piotr Lech Czarny, Paulina Wigner, Justyna Strycharz, Ewa Świderska, Ewelina Synowiec, Magdalena Szatkowska, Agnieszka Śliwińska, Monika Ewa Talarowska, Janusz Szemraj, Kuan‐Pin Su et al. · 2019 · The World Journal of Biological Psychiatry
  133. Increased mRNA levels of the mitochondrial complex I 75-kDa subunit
    Claudia Mehler‐Wex, Johanna Catharina Duvigneau, Romana T. Hartl, Dorit Ben‐Shachar, Andreas Warnke, Manfred Gerlach · 2006 · European Child & Adolescent Psychiatry
  134. Blunted adenosine A2a receptor function in platelets in patients with major depression
    Michael Berk, Helene Plein, Dulcie Ferreira, Brian Jersky · 2001 · European Neuropsychopharmacology
  135. Mitochondrial complex I and III gene mRNA levels in schizophrenia, and their relationship with clinical features
    Süleyman Akarsu, Deniz Torun, Abdullah Bolu, Murat Erdem, Salih Kozan, Mehmet Ak, Hatice Akar, Özcan Uzun · 2014 · Journal of Molecular Psychiatry
  136. Toxicity of lithium on isolated heart mitochondria and cardiomyocyte: A justification for its cardiotoxic adverse effect
    Ahmad Salimi, Ehsan Gholamifar, Parvaneh Naserzadeh, Mir‐Jamal Hosseini, Jalal Pourahmad · 2016 · Journal of Biochemical and Molecular Toxicology
  137. In Depth Analysis of Kinase Cross Screening Data to Identify CAMKK2 Inhibitory Scaffolds
    Sean N. O’Byrne, John W. Scott, Joseph R. Pilotte, André da Silva Santiago, Christopher G. Langendorf, Jonathan S. Oakhill, Benjamin J. Eduful, Rafael M. Couñago, Carrow I. Wells, William J. Zuercher et al. · 2020 · Molecules
  138. Mitochondrial dysfunction in psychiatric morbidity: current evidence and therapeutic prospects
    Galila Agam, Lilah Toker · 2015 · Neuropsychiatric Disease and Treatment
  139. Mitoproteomics: Tackling Mitochondrial Dysfunction in Human Disease
    María Gómez‐Serrano, Emilio Camafeita, Marta Loureiro, Belén Peral · 2018 · Oxidative Medicine and Cellular Longevity
  140. S-Adenosylmethionine (SAMe) monotherapy for depression: an 8-week double-blind, randomised, controlled trial
    Jerome J. Sarris, Jenifer Murphy, Con K. K. Stough, David Mischoulon, Chad Bousman, Patricia MacDonald, Laura Adams, Sonia M. Nazareth, Georgina Oliver, Lachlan Cribb et al. · 2019 · Psychopharmacology
  141. Mitochondrial Dysfunctions in Bipolar Disorder: Effect of the Disease and Pharmacotherapy
    Tereza Cikánková, Ekaterina Sigitova, Martina Zvěřová, Zdeněk Fišar, Jiří Raboch, Jana Hroudová · 2016 · CNS & Neurological Disorders - Drug Targets
  142. The Neurogenic Basic Helix-Loop-Helix Transcription Factor NeuroD6 Concomitantly Increases Mitochondrial mass and Regulates Cytoskeletal Organization in the Early Stages of Neuronal Differentiation
    佐藤 郡衛, Martine Uittenbogaard, Jeongae Yoon, Anne Chiaramello · 2009 · ASN NEURO
  143. Metabolic clockwork
    Benedetto Grimaldi, Paolo Sassone‐Corsi · 2007 · Nature
  144. Pharmacological targeting of redox regulation systems as new therapeutic approach for psychiatric disorders: A literature overview.
    S. Schiavone, L. Trabace · 2016 · Pharmacological Research
  145. Magnesium oxide augmentation of verapamil maintenance therapy in mania
    A. James Giannini, Ann M. Nakoneczie, Steven M. Melemis, James Ventresco, Maggie Condon · 2000 · Psychiatry Research
  146. Observed Effects of Creatine Monohydrate in a Patient With Depression and Fibromyalgia
    Daniela Amital, Tali H. Vishne, Alan Rubinow, JOSEPH LEVINE · 2006 · American Journal of Psychiatry
  147. Creatine affords protection against glutamate-induced nitrosative and oxidative stress
    Mauricio Peña Cunha, Vicente Lieberknecht, Ana Belén Ramos-Hryb, Gislaine Olescowicz, Fabiana Kalyne Ludka, Carla I. Tasca, Nelson Horácio Gabilan, Ana Lúcia S. Rodrigues · 2016 · Neurochemistry International
  148. Delayed administration of ethyl eicosapentate improves local cerebral blood flow and metabolism without affecting infarct volumes in the rat focal ischemic model
    Toshiya Katsumata, Yasuo Katayama, Rinnosuke Obo, Hiromi Muramatsu, Tatsuo Ohtori, Akiro Terashi · 1999 · European Journal of Pharmacology
  149. Expression analyses of the mitochondrial complex I 75-kDa subunit in early onset schizophrenia and autism spectrum disorder: increased levels as a potential biomarker for early onset schizophrenia
    Regina Taurines, Johannes Thome, Johanna Catharina Duvigneau, Sarah Forbes-Robertson, Liya Yang, Karin Maria Egberts, Jasmin Romanos, Sabine Müller, Manfred Gerlach, Claudia Mehler‐Wex · 2009 · European Child & Adolescent Psychiatry
  150. Acute and chronic treatment with quetiapine induces antidepressant-like behavior and exerts antioxidant effects in the rat brain
    Zuleide Maria Ignácio, Gislaine Z. Réus, Helena M. Abelaira, Airam Barbosa de Moura, Thays G. de Souza, Danyela Matos, Mariana Pereira de Souza Goldim, Khiany Mathias, Leandro Garbossa, Fabricia Cardoso Petronilho et al. · 2017 · Metabolic Brain Disease
  151. Possible Benefit of Dietary Carnosine towards Depressive Disorders
    Alan R. Hipkiss · 2014 · Aging and Disease
  152. Mitochondrial IV complex and brain neurothrophic derived factor responses of mice brain cortex after downhill training
    Aderbal S. Aguiar, Talita Tuon, Cleber Aurino Pinho, Luciano Acordi da Silva, Ana C. Andreazza, Flávio Pereira Kapczinski, João Quevedo, Emilio Luiz STRECK, Ricardo A. Pinho · 2007 · Neuroscience Letters
  153. Pyruvate uptake is inhibited by valproic acid and metabolites in mitochondrial membranes
    Cátia C.P. Aires, Graça Soveral, Paula B. Luis, H.J. ten Brink, Isabel Tavares de Almeida, Marinus Durán, Ronald J. A. Wanders, Margarida F. B. Silva · 2008 · FEBS Letters
  154. Targeting the BH3-interacting domain death agonist to develop mechanistically unique antidepressants
    Oz Malkesman, D R Austin, Tyson R. Tragon, Ioline D. Henter, John C. Reed, Maurizio Pellecchia, G Chen, H.K. Manji · 2011 · Molecular Psychiatry
  155. Elevated [ 3 H]inositol 1,4,5-trisphosphate binding sites and expressed inositol 1,4,5-trisphosphate receptor protein level in platelets of depressed patients
    Yogesh Dwivedi, Philip G. Janicak, G.N. Pandey · 1998 · Psychopharmacology
  156. Systemic illness moderates the impact of N-acetyl cysteine in bipolar disorder
    Pedro Vieira da Silva Magalhães, Olivia May Dean, Ashley Ian Bush, David Copolov, D. Weisinger, Gin Singh Malhi, Kristy Kohlmann, Sue Jeavons, Ian Schapkaitz, Murray Anderson‐Hunt et al. · 2011 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  157. Effects of fluoxetine on plasticity and apoptosis evoked by chronic stress in rat prefrontal cortex
    Ana D. Djordjevic, Jelena Djordjevic, Ivana Elaković, Miroslav Adžić, Gordana M. Matić, Marija B. Radojcic · 2012 · European Journal of Pharmacology
  158. Peripheral blood lymphocytes from patients with bipolar disorder demonstrate apoptosis and differential regulation of advanced glycation end products and S100B
    Paraskevi Moutsatsou, James N. Tsoporis, Vasileios Salpeas, Ekaterini S. Bei, B. Alevizos, C. Anagnostara, Shehla Izhar, Gerald A. Proteau, Emmanouil Rizos, Erifili E. Hatziagelaki et al. · 2014 · Clinical Chemistry and Laboratory Medicine (CCLM)
  159. Mitochondrial metabolism in early neural fate and its relevance for neuronal disease modeling
    Carmen Lorenz, Alessandro Prigione · 2017 · Current Opinion in Cell Biology
  160. Important Role of Mitochondria and the Effect of Mood Stabilizers on Mitochondrial Function
    Matej Ľupták, Jana Hroudová · 2019 · Physiological Research
  161. NMDA-evoked consumption and recovery of mitochondrially targeted aequorin suggests increased Ca2+ uptake by a subset of mitochondria in hippocampal neurons
    Kyle T. Baron, Guang Jian Wang, Rodolfo A. Padua, Colin Campbell, Stanley A. Thayer · 2003 · Brain Research
  162. Quality control in mitochondria: use it, break it, fix it, trash it
    Benoı̂t Kornmann · 2014 · F1000Prime Reports
  163. Acute and Chronic Treatments with Quetiapine Increase Mitochondrial Respiratory Chain Complex Activity in the Rat Brain
    Zuleide Maria Ignácio, Gislaine Z. Réus, Helena M. Abelaira, Stephanie E. Titus, Anelise Scussel Carlessi, Jaine R. da Luz, Beatriz I. Matias, Lívia Bruchchen, Milena Carvalho‐Silva, Lara Gomes et al. · 2015 · Current Neurovascular Research
  164. Novel routes to bipolar disorder drug discovery
    Nicolas Hoertel, Pierre de Maricourt, Philip A. P. M. Gorwood · 2013 · Expert Opinion on Drug Discovery
  165. Activation of cloned BKCa channels in nitric oxide-induced apoptosis of HEK293 cells
    Yu‐Guang Ma, Ling Dong, Xiaolong Ye, Chang-Lei Deng, Jiu‐Hua Cheng, Wenchao Liu, Jin Ma, Yao‐Ming Chang, Man‐Jiang Xie · 2009 · APOPTOSIS
  166. A genetic variant in CAMKK2 gene is possibly associated with increased risk of bipolar disorder
    Minoo Atakhorrami, Simin Rahimi-Aliabadi, Javad Jamshidi, Elham Moslemi, Abolfazl Movafagh, Mina Ohadi, Arash Mirabzadeh, Babak Emamalizadeh, Hamid Ghaedi, Fatemeh Gholipour et al. · 2015 · Journal of Neural Transmission
  167. Muscular and mitochondrial effects of long-term fluoxetine treatment in mice, combined with physical endurance exercise on treadmill
    Abdulkarim Tutakhail, Qand Agha Nazari, Sarah Khabil, Alain Michel Gardier, François Coudoré · 2019 · Life Sciences
  168. Requirement of AMPK activation for neuronal metabolic-enhancing effects of antidepressant paroxetine
    Jihyeon Jeong, Minsun Park, Jeong Seon Yoon, Hyunjeong Kim, Su Kyoung Lee, Eun Min Lee, Kee Namkoong, Eosu Kim · 2015 · Neuroreport
  169. Physical Activity as a Predictor of Clinical Trial Outcomes in Bipolar Depression: A Subanalysis of a Mitochondrial-Enhancing Nutraceutical Randomized Controlled Trial
    Melanie M. Ashton, Mohammadreza Mohebbi, Alyna Turner, Wolfgang Marx, Michael Berk, Gin Singh Malhi, Chee H. Ng, Sue Cotton, Seetal Dodd, Jerome J. Sarris et al. · 2019 · The Canadian Journal of Psychiatry
  170. Identification of diagnostic markers for major depressive disorder by cross-validation of data from whole blood samples
    Huimei Wang, Mingwei Zhang, Qiqi Xie, Jin Ming Yu, Qi Yan, Qiuyuan Yue · 2019 · PeerJ
  171. Fluvoxamine alters the activity of energy metabolism enzymes in the brain
    Gabriela Kozuchovski Ferreira, Mariane R. Cardoso, Isabela C. Jeremias, Cinara Ludvig Gonçalves, Karolina V. Freitas, Rafaela Antonini, Giselli Scaini, Gislaine Tezza Rezin, João Quevedo, Emilio Luiz STRECK · 2014 · Brazilian Journal of Psychiatry
  172. A study of oxidative stress and influence of antiox idant vitamins supplementation in patients with major depression.
    Santoshi R. Ghodake, Adinath N. Suryakar, Prabhakar M. Kulhalli, Ramch, R.K. Padalkar, Abdul Kayyum Shaikh · 2012 · Current Neurobiology
  173. The Importance of Melatonin and Mitochondria Interaction in Mood Disorders and Schizophrenia: A Current Assessment
    Abdülhadi Cihangir Uğuz, Kadir Demirci, Javier Espino · 2016 · Current Medicinal Chemistry
  174. Mitochondrial signaling in inflammation-induced depressive behavior in female and male rats: The role of glucocorticoid receptor
    Zeljka Brkic, Minja Milosavljevic, Emilija Glavonic, Miroslav Adžić · 2019 · Brain Research Bulletin
  175. Regulation of leukocyte tricarboxylic acid cycle in drug-naïve Bipolar Disorder
    RAFAEL TEIXEIRA DE SOUSA, Emilio Luiz STRECK, Orestes Vicente Forlenza, André R. Brunoni, Marcus V. Zanetti, Gabriela Kozuchovski Ferreira, Breno Satler Diniz, Luis Valmor Portela, Andre Ferrer Carvalho, Carlos A. Zarate et al. · 2015 · Neuroscience Letters
  176. Distinct modifications of hippocampal glucocorticoid receptor phosphorylation and FKBPs by lipopolysaccharide in depressive female and male rats
    Zeljka Brkic, Ester Francija, Zorica Petrovic, Dusanka Franic, Iva Lukić, Miloš Mitić, Miroslav Adžić · 2017 · Journal of Psychopharmacology
  177. Glutamate‐Induced Over‐Expression of GAD Is Down‐Regulated by Acetyl‐L‐Carnitine in Rat Islet Cells
    Yanlei Hao, Anthony S. Basile, Guang Chen, Lei Zhang · 2004 · Endocrine Research
  178. Challenges in drug target discovery in bipolar disorder
    Murtada Alsaif, Frieder Haenisch, Paul C. Guest, Hassan Rahmoune, Sabine Bahn · 2013 · Expert Opinion on Therapeutic Targets
  179. Caloric Restriction Followed by High Fat Feeding Predisposes to Oxidative Stress in Skeletal Muscle Mitochondria
    Raffaella Crescenzo, Francesca Bianco, Paola Coppola, Arianna Mazzoli, Giovanna Liverini, Susanna Iossa · 2013 · Hormone and Metabolic Research